One Capital Management Llc decreased its stake in Bristol Myers Squibb Co (BMY) by 22.26% based on its latest 2018Q3 regulatory filing with the SEC. One Capital Management Llc sold 4,947 shares as the company’s stock declined 13.60% with the market. The institutional investor held 17,280 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $1.07 million, down from 22,227 at the end of the previous reported quarter. One Capital Management Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $85.54B market cap company. The stock increased 2.81% or $1.43 during the last trading session, reaching $52.39. About 55.86 million shares traded or 269.90% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 14.97% since February 28, 2018 and is downtrending. It has underperformed by 14.97% the S&P500. Some Historical BMY News: 12/03/2018 – Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors; 31/05/2018 – CLINIGEN GROUP- AGREEMENT WILL LEAD TO TRANSFER OF MARKETING AUTHORISATIONS FROM BMS TO CLINIGEN, WHICH WILL LIKELY BE COMPLETED IN FIRST HALF OF 2019; 27/03/2018 – U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTS BRISTOL-MYERS SQUIBB’S APPLICATION FOR OPDIVO (NIVOLUMAB) PLUS YERVOY (IPILIMUMAB) FOR PREVIOUSLY TREATED PATIENTS WITH MSI-H OR DMMR METASTATIC; 16/05/2018 – GENENTECH – IN PHASE lll IMPOWER150 STUDY, SURVIVAL ADVANTAGE FOR TECENTRIQ-AVASTIN COMBO REGIMEN WAS SEEN IN ALL EXPLORATORY PATIENT SUBGROUPS ANALYZED; 26/04/2018 – BMY FIRST QUARTER EARNINGS CALL BEGINS; 18/04/2018 – BRISTOL-MYERS SQUIBB – OPDIVO SUBMISSION BASED ON SAFETY AND EFFICACY DATA FROM SCLC COHORT OF PHASE 1/2 CHECKMATE -032 TRIAL; 16/04/2018 – BRISTOL-MYERS IN PACT WITH JANSSEN TO DEVELOP BMS-986177; 17/03/2018 – Xilinx Technology Enables 5G for Hyper-Connected Urban Society at University of Bristol Smart Internet Lab; 27/03/2018 – Applied BioMath, LLC Announces Haiqing Wang, PhD, Bristol-Myers Squibb as Featured Speaker at QSP Day; 30/04/2018 – FDA GRANTS PRIORITY REVIEW TO MERCK’S SBLA FOR KEYTRUDA®

Markston International Llc increased its stake in Goldman Sachs Group Inc. (GS) by 6.26% based on its latest 2018Q3 regulatory filing with the SEC. Markston International Llc bought 2,288 shares as the company’s stock declined 22.89% with the market. The institutional investor held 38,850 shares of the finance company at the end of 2018Q3, valued at $8.71 million, up from 36,562 at the end of the previous reported quarter. Markston International Llc who had been investing in Goldman Sachs Group Inc. for a number of months, seems to be bullish on the $72.35B market cap company. The stock decreased 0.69% or $1.37 during the last trading session, reaching $196.74. About 1.02 million shares traded. The Goldman Sachs Group, Inc. (NYSE:GS) has declined 28.05% since February 28, 2018 and is downtrending. It has underperformed by 28.05% the S&P500. Some Historical GS News: 16/03/2018 – With a change of leadership, Goldman reignites an old debate; 29/05/2018 – RED ELECTRICA REE.MC : GOLDMAN SACHS RAISES TO NEUTRAL FROM SELL; 02/04/2018 – Goldman faces class action suit over pay discrimination; 09/03/2018 – Banking analyst Dick Bove calls possible Blankfein exit from Goldman ‘wonderful’ news; 28/03/2018 – APPLE INC AAPL.O : GOLDMAN SACHS REDUCES IPHONE SALES ESTIMATE FOR MARCH QTR BY 1.7 MLN UNITS TO 53.0 MLN UNITS; 14/05/2018 – Goldman Sachs tells its clients to buy high-growth companies; 30/03/2018 – GOLDMAN SACHS WOMEN WIN CLASS-ACTION STATUS IN GENDER BIAS CASE; 14/05/2018 – Nicholas Carlson: Scoop: A new Game of Thrones just started at Goldman!; 12/03/2018 – Goldman Names Solomon as Next in Line to Replace CEO Blankfein; 09/03/2018 – Goldman Co-Presidents Leading Candidates to Replace Blankfein

One Capital Management Llc, which manages about $676.36 million and $553.04M US Long portfolio, upped its stake in Ishares Tr (MUB) by 17,534 shares to 163,396 shares, valued at $17.64 million in 2018Q3, according to the filing. It also increased its holding in Ishares Tr Sh Tr (CSJ) by 303,399 shares in the quarter, for a total of 623,828 shares, and has risen its stake in Ishares Tr (CIU).

Investors sentiment increased to 0.88 in Q3 2018. Its up 0.10, from 0.78 in 2018Q2. It is positive, as 41 investors sold BMY shares while 532 reduced holdings. 119 funds opened positions while 388 raised stakes. 1.14 billion shares or 0.62% less from 1.14 billion shares in 2018Q2 were reported. Fulton Breakefield Broenniman Limited Liability Corporation invested 0.96% in Bristol-Myers Squibb Company (NYSE:BMY). Clear Harbor Asset Ltd Liability holds 7,908 shares or 0.08% of its portfolio. Td Asset Management holds 0.1% in Bristol-Myers Squibb Company (NYSE:BMY) or 1.05 million shares. Howe Rusling Inc holds 0.05% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 5,278 shares. Richard Bernstein Advsr Limited Liability Corporation holds 0.12% in Bristol-Myers Squibb Company (NYSE:BMY) or 66,900 shares. Independent Invsts Inc has 0.96% invested in Bristol-Myers Squibb Company (NYSE:BMY). Woodmont Invest Counsel Limited Liability Corp reported 19,633 shares. Wealthfront Corporation reported 0.02% in Bristol-Myers Squibb Company (NYSE:BMY). Curbstone Fincl Mgmt has invested 0.19% in Bristol-Myers Squibb Company (NYSE:BMY). Duff & Phelps Investment Mgmt Company, a Illinois-based fund reported 17,185 shares. Associates Ny holds 0.28% or 3,650 shares in its portfolio. Cap Invest reported 44,689 shares stake. Virginia-based Palladium Prtnrs Ltd Liability Corporation has invested 0.25% in Bristol-Myers Squibb Company (NYSE:BMY). New Jersey Better Educational Savings stated it has 0.76% in Bristol-Myers Squibb Company (NYSE:BMY). Monetta Fincl has invested 0.62% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Recent Purchase: Bristol-Myers Squibb – Seeking Alpha” on October 29, 2018, also Seekingalpha.com with their article: “Bristol-Myers Squibb Q4 2018 Earnings Preview – Seeking Alpha” published on January 23, 2019, Seekingalpha.com published: “Bristol-Myers Squibb goes ex-dividend tomorrow – Seeking Alpha” on January 02, 2019. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Seekingalpha.com and their article: “I’m Buying Bristol-Myers Down Near 52-Week Lows – Seeking Alpha” published on April 18, 2018 as well as Seekingalpha.com‘s news article titled: “Bristol-Myers Squibb’s Opdivo flunks late-stage lung cancer study – Seeking Alpha” with publication date: October 12, 2018.

Markston International Llc, which manages about $1.63B and $932.26M US Long portfolio, decreased its stake in Travelers Companies Inc. (NYSE:TRV) by 2,956 shares to 109,550 shares, valued at $14.21 million in 2018Q3, according to the filing. It also reduced its holding in Wells Fargo & Company (NYSE:WFC) by 7,950 shares in the quarter, leaving it with 188,457 shares, and cut its stake in Udr Inc. (NYSE:UDR).

Investors sentiment increased to 1.2 in Q3 2018. Its up 0.17, from 1.03 in 2018Q2. It increased, as 43 investors sold GS shares while 343 reduced holdings. 99 funds opened positions while 366 raised stakes. 252.31 million shares or 2.19% less from 257.97 million shares in 2018Q2 were reported. Bradley Foster Sargent Ct reported 1,831 shares. 94,466 are owned by Dupont Capital. Rocky Mountain Advisers Limited Company holds 100 shares or 0.08% of its portfolio. Fayez Sarofim And holds 1,502 shares. Buckingham Asset Ltd Liability Corporation accumulated 1,120 shares. Bb&T Secs Limited Co reported 0.08% in The Goldman Sachs Group, Inc. (NYSE:GS). Syntal Prtnrs Ltd Liability Com holds 0.12% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS) for 1,500 shares. Csat Investment Advisory Lp invested in 2.01% or 15,716 shares. Cornerstone holds 1,000 shares or 0.03% of its portfolio. M&R holds 0.01% in The Goldman Sachs Group, Inc. (NYSE:GS) or 200 shares. Murphy Cap Management Incorporated has invested 0.2% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Eastern Bancorporation reported 0.03% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Verition Fund Ltd Llc has 40,773 shares for 0.33% of their portfolio. First Personal Fincl Svcs reported 0.01% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Essex Fincl Services Incorporated owns 8,940 shares or 0.44% of their US portfolio.